Implications of Benefit Design in Medicare Prescription Drug Plans

×

There has been considerable controversy surrounding the basic Medicare Part D prescription drug benefit, particularly the use of cost-sharing in private drug plans and its impact on Medicare beneficiaries' costs and clinical outcomes. To date, there has been no scientific analysis of beneficiaries' actual experiences under Part D to assess these impacts. Using 2006 data from both standalone Part D plans and Medicare Advantage plans, this project will examine these issues and produce empirical evidence of the impact of Part D coverage, highlight important areas for further research, and inform efforts to improve the prescription drug benefit.

Grant Details

Grantee Organization:
Kaiser Foundation Research Institute
Principal Investigator:
John Hsu, M.D., M.B.A., M.S.C.E.
Award Amount:
$334,511.00
Approval Date:
November 14, 2007

Forgot Password

An email has been sent to {{email}} with your reset password.

Account was not found. Please go to the login page and enter a new password.

Account was not found. Please try again with a different email address.

There was an error when attempting to send to {{email}}. Please contact an administrator.